NASDAQ:FWP - Forward Pharma A/S Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$6.49
▼ -0.01 (-0.15%)

This chart shows the closing price for FWP by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Forward Pharma A/S Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for FWP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for FWP

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Forward Pharma A/S in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $6.49.

This chart shows the closing price for FWP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Forward Pharma A/S. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/3/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/30/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/27/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/27/2017Jefferies Financial GroupReiterated RatingHold$5.00 ➝ $6.00Medium
4/18/2017Jefferies Financial GroupSet Price TargetHold$22.00Low
4/3/2017SVB LeerinkSet Price TargetBuy$28.00High
4/3/2017Jefferies Financial GroupDowngradeBuy ➝ Hold$41.00 ➝ $24.00High
4/3/2017JMP SecuritiesDowngradeOutperform ➝ Market PerformHigh
3/31/2017Jefferies Financial GroupReiterated RatingBuy ➝ Hold$41.00Low
12/1/2016JMP SecuritiesReiterated RatingBuyN/A
11/30/2016SVB LeerinkSet Price TargetBuy$45.00N/A
11/23/2016SVB LeerinkSet Price TargetBuy$44.00N/A
9/27/2016Jefferies Financial GroupReiterated RatingBuy$40.00N/A
(Data available from 9/27/2016 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/1/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/31/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/30/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/29/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/29/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/28/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/27/2021

Current Sentiment

  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Forward Pharma A/S logo
Forward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 1, 2005 and is headquartered in Copenhagen, Denmark.
Read More

Today's Range

Now: $6.49
Low: $6.24
High: $6.49

50 Day Range

MA: $8.88
Low: $5.97
High: $17.66

52 Week Range

Now: $6.49
Low: $5.76
High: $20.31

Volume

17,800 shs

Average Volume

188,508 shs

Market Capitalization

$44.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.69

Frequently Asked Questions

What sell-side analysts currently cover shares of Forward Pharma A/S?

The following Wall Street analysts have issued reports on Forward Pharma A/S in the last year:
View the latest analyst ratings for FWP.

What is the current price target for Forward Pharma A/S?

0 Wall Street analysts have set twelve-month price targets for Forward Pharma A/S in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Forward Pharma A/S in the next year.
View the latest price targets for FWP.

What is the current consensus analyst rating for Forward Pharma A/S?

Forward Pharma A/S currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for FWP.

How do I contact Forward Pharma A/S's investor relations team?

Forward Pharma A/S's physical mailing address is OSTERGADE 24A 1, COPENHAGEN G7, 1100. The biotechnology company's listed phone number is (453) 344-4242 and its investor relations email address is [email protected] The official website for Forward Pharma A/S is www.forward-pharma.com.